JAK2 is an important signal transducer in IL-33-induced NF-κB activation

Cellular Signalling

Volumn 23, Issue 2, 2011, Pages 363-370

  Funakoshi Tago, Megumi ^a   Tago, Kenji ^b   Sato, Yoshinori ^a   Tominaga, Shin Ichi ^c   Kasahara, Tadashi ^a  

^a KEIO UNIVERSITY   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

IL 33; JAK2; NF B; ST2L

Indexed keywords

CXCL1 CHEMOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 33; INTERLEUKIN 6; JANUS KINASE 2; MONOCYTE CHEMOTACTIC PROTEIN 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; INTERLEUKINS; JANUS KINASE 2; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NIH 3T3 CELLS; SIGNAL TRANSDUCTION; TYRPHOSTINS;

EID: 78649840537     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2010.10.006     Document Type: Article

References (19)

1. Tominaga S. FEBS Lett. 1989, 258:301-304.
2. Yanagisawa K., Takagi T., Tsukamoto T., Tetsuka T., Tominaga S. FEBS Lett. 1993, 318:83-87.
3. Yanagisawa K., Naito Y., Kuroiwa K., Arai T., Furukawa Y., Tomizuka H., Miura Y., Kasahara T., Tetsuka T., Tominaga S. J. Biochem. 1997, 121:95-103.
4. Coyle A.J., Lloyd C., Tian J., Nguyen T., Erikkson C., Wang L., Ottoson P., Persson P., Delaney T., Lehar S., Lin S., Poisson L., Meisel C., Kamradt T., Bjerke T., Levinson D., Gutierrez-Ramos J.C. J. Exp. Med. 1999, 190:895-902.
5. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. Immunity 2005, 23:479-490.
6. Funakoshi-Tago M., Tago K., Hayakawa M., Tominaga S., Ohshio T., Sonoda Y., Kasahara T. Cell. Signal. 2008, 20:1679-1686.
7. Funakoshi-Tago M., Shimizu T., Tago K., Nakamura M., Itoh H., Sonoda Y., Kasahara T. Biochem. Pharmacol. 2008, 76:662-671.
8. Funakoshi-Tago M., Nakamura K., Tsuruya R., Hatanaka M., Mashino T., Sonoda Y., Kasahara T. Int. Immunopharmacol. 2010, 10:562-571.
9. Funakoshi-Tago M., Tago K., Abe M., Sonoda Y., Kasahara T. J. Biol. Chem. 2010, 285:5296-5307.
10. Ali S., Huber M., Kollewe C., Bischoff S.C., Falk W., Martin M.U. Proc. Natl Acad. Sci. USA 2007, 104:18660-18665.
11. Lingel A., Weiss T.M., Niebuhr M., Pan B., Appleton B.A., Wiesmann C., Bazan J.F., Fairbrother W.J. Structure 2009, 17:1398-1410.
12. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. Nature 1996, 383:443-446.
13. Drube S., Heink S., Walter S., Löhn T., Grusser M., Gerbaulet A., Berod L., Schons J., Dudeck A., Freitag J., Grotha S., Reich D., Rudeschko O., Norgauer J., Hartmann K., Roers A., Kamradt T. Blood 2010, 115:3899-3906.
14. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. Cell 1997, 91:243-252.
15. Kralovics R., Passamonti F., Buser A.S., Teo S.S., Tiedt R., Passweg J.R., Tichelli A., Cazzola M., Skoda R.C. N. Engl. J. Med. 2005, 352:1779-1790.
16. Funakoshi-Tago M., Pelletier S., Moritake H., Parganas E., Ihle J.N. Mol. Cell. Biol. 2008, 28:1792-1801.
17. Kimura A., Naka T., Muta T., Takeuchi O., Akira S., Kawase I., Kishimoto T. Proc. Natl Acad. Sci. USA 2005, 102:17089-17094.
18. Townsend M.J., Fallon P.G., Matthews D.J., Jolin H.E., McKenzie A.N. J. Exp. Med. 2000, 191:1069-1076.
19. Sofi M.H. Mol. Immunol. 2009, 46:1443-1450.